L-2HGA Genetic Testing Guide for At-Risk Dog Breeds

L-2 hydroxyglutaric aciduria (L-2HGA) is a hereditary neurometabolic disorder impacting the nervous system in certain dog breeds. It leads to a damaging accumulation of L-2-hydroxyglutaric acid in body tissues, causing progressive neurological symptoms. Responsible breeding practices and early genetic testing help reduce the occurrence of this condition, especially in breeds like the Staffordshire Bull Terrier puppies commonly affected in the United States.

What Is L-2 Hydroxyglutaric Aciduria in Dogs?

L-2HGA results from mutations in the L2HGDH gene that impair the normal breakdown of L-2-hydroxyglutaric acid. This acid builds up notably in the urine, blood plasma, and cerebrospinal fluid, causing damage primarily to brain areas like the cerebellum responsible for coordination and movement.

Symptoms often manifest between 6 months and 3 years of age but can appear as early as birth or later in some cases. Common signs include unsteady walking (ataxia), poor balance, tremors, muscle stiffness, seizures, and changes in behavior. The degree of severity varies widely; while some dogs may live well into their teens with supportive care, others require euthanasia due to rapid progression.

Breeds Most Susceptible in the U.S.

In the United States, L-2HGA is most frequently documented in the Staffordshire Bull Terrier, but cases have also been identified in breeds such as the West Highland White Terrier, Yorkshire Terrier, American Staffordshire Terrier, and related pit bull-type breeds. Genetic screening of breeding stock is critical to prevent passing this mutation to future litters.

Genetic Inheritance Explained

L-2HGA is inherited as an autosomal recessive trait, meaning that a dog must inherit two copies of the mutated gene (one from each parent) to develop the disease. Dogs can be classified as:

• Clear (homozygous normal): Dogs with no copies of the mutation, unaffected and unable to pass the gene.
• Carrier (heterozygous): Dogs with one copy of the mutation. They usually remain healthy but can transmit the gene to offspring.
• Affected (homozygous mutant): Dogs with two copies of the mutation and who will develop L-2HGA, passing it to all their pups.

Breeding combinations result in different risks:

• Two clear dogs will produce only clear puppies.
• Two affected dogs produce only affected puppies.
• A clear dog bred with an affected dog produces carriers only.
• A carrier bred with an affected dog results in 50% affected and 50% carriers.
• Two carriers have 25% clear, 50% carriers, and 25% affected puppies.

How Is L-2HGA Testing Done?

DNA testing via cheek swabs is the most reliable method to detect L-2HGA status. Samples are submitted to veterinary genetic laboratories that analyze mutations in the L2HGDH gene. Results determine if a dog is clear, a carrier, or affected, with nearly full accuracy due to duplicate testing protocols.

Several U.S.-accessible labs offer testing, including Animal Genetics, Wisdom Panel, Koko Genetics, and Alpha Dog DNA. The tests typically cost around $45 with a turnaround time of 3 to 5 business days.

For symptomatic dogs, diagnosis can be supported by MRI scans revealing typical brain anomalies and biochemical tests detecting elevated L-2-hydroxyglutaric acid in urine or cerebrospinal fluid.

Best Practices for Responsible Breeding and Care

Breeders should test prospective breeding dogs early and only breed carriers to clear dogs to avoid producing affected puppies. Since there is no known cure, preventing L-2HGA is the most effective way to reduce suffering.

Owners of affected dogs should work closely with their veterinarians and potentially veterinary neurologists to manage symptoms such as seizures, stiffness, and behavioral changes through supportive care, including anticonvulsants and physical therapy.

Summary

L-2 Hydroxyglutaric Aciduria is a serious inherited neurological disorder in various U.S. dog breeds, notably the Staffordshire Bull Terrier. Genetic testing helps identify carriers and affected dogs early, enabling breeders to make informed choices and improve dog health.

Testing your Staffordshire Bull Terrier or Yorkshire Terrier contributes to reducing this disease’s impact and supports healthier future generations.